0001439222-22-000016.txt : 20220223 0001439222-22-000016.hdr.sgml : 20220223 20220223161010 ACCESSION NUMBER: 0001439222-22-000016 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220222 FILED AS OF DATE: 20220223 DATE AS OF CHANGE: 20220223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Burns James William CENTRAL INDEX KEY: 0001900772 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36014 FILM NUMBER: 22663643 MAIL ADDRESS: STREET 1: C/O AGIOS PHARMACEUTICALS STREET 2: 88 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AGIOS PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001439222 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 88 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-649-8600 MAIL ADDRESS: STREET 1: 88 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: AGIOS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20080703 4 1 wf-form4_164565059136535.xml FORM 4 X0306 4 2022-02-22 0 0001439222 AGIOS PHARMACEUTICALS, INC. AGIO 0001900772 Burns James William 88 SIDNEY STREET CAMBRIDGE MA 02139 0 1 0 0 Chief Legal Officer Common stock 2022-02-22 4 M 0 724 0 A 15008 D Common stock 2022-02-22 4 F 0 215 29.08 D 14793 D Restricted stock units 2022-02-22 4 M 0 724 0 D Common stock 724.0 0 D Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units were granted on February 22, 2019. Beginning on February 22, 2020, the shares underlying the restricted stock units will vest in three equal annual installments. /s/ William Cook, as Attorney in Fact for James Burns 2022-02-23